Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis
Clinical trial NCT05254457 · COMPLETED
Trial details
- NCT number
- NCT05254457
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-14
- Primary completion
- 2024-03-21
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.